Pharma

A cancer patient in Mumbai could soon pay 15 per cent less for European biologics. An Indian pharmaceutical manufacturer might capture new European markets worth billions. Yet the same trade agreement enabling both outcomes has sparked fierce debate about whether India‘s generic drug industry—supplying 20 per cent of global generics and keeping essential medicines affordable […]

Every rupee Indian insurers spend today on preventive health screenings saves them three to four rupees in claims tomorrow—a mathematical reality transforming how the nation approaches healthcare economics. As medical inflation gallops ahead at 13% in 2025, amongst Asia’s steepest rates, insurers and corporate health planners face an existential choice: continue absorbing spiralling hospitalisation costs

India’s digital health revolution presents a curious paradox: platforms like eSanjeevani have delivered over 340 million consultations by early 2025, transforming healthcare access for millions who previously faced hours-long queues or inaccessible specialists. Urban adoption soars past 60%, whilst tier-2 and tier-3 cities accelerate at over 20% compound annual growth rates, painting a picture of

A simple scan could be the difference between genuine medicine and a potentially lethal counterfeit. In chemist shops across India, a quiet revolution is unfolding on pharmacy shelves—every medicine package now carries a QR code that transforms patients from passive consumers into active participants in drug safety monitoring. Since August 2023, the Drugs Controller General